The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The
https://
ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more about our disclaimer.
-
•
Eponyms: whose name should be given and why should this reduce stigma?
-
•
Core symptoms/syndrome: psychosis is a defining part, but it does not reflect the whole picture.
-
•
Susceptibility: this would not necessarily include illness manifestation.
-
•
(Neuro)psychological dysfunction: describes just pars pro toto and is difficult to understand.
-
•
Neurotransmitter dysfunction: describes only part of the illness mechanism.
-
•
Metaphoric (Asian examples): questionable as a precise and scientific term.
Despite numerous well thought out suggestions, there is no universal agreement on any of the proposed new names for schizophrenia so far. Moreover, which one would be best suited to reduce the associated illness stigma and work in different socio-cultural contexts?
Outcomes from previous name changes
The increased interest in changing the name of schizophrenia in recent years has supposedly been influenced by the movement in Japan which was the first country that introduced a new name for the disorder (Maruta and Matsumoto,
2017
). In 2011, South Korea followed this development and replaced ‘mind-split disease’ with ‘attunement disorder’ (Lasalvia
et al
.,
2015
). In Taiwan ‘mind-split disease’ was replaced by ‘dysregulation of thought and perception’ in 2012. Hong-Kong introduced a new name (‘dysfunction of thought and perception’) along with the old term ‘splitting of mind’ which is still in use (Maruta and Matsumoto,
2017
).
There are studies that confirm the positive effect and the reduction of stigma after introduction of these name changes in Japan and South Korea. It is reported that the new names evoke less prejudice, improve communication between clinicians and patients and promote social integration (Lasalvia
et al
.,
2015
; Lasalvia,
2018
). But it was also found that the new term was not easy to understand for the public without further explanation. In addition, the media continued using the established name of the disorder (Lasalvia
et al
.,
2015
).
However, there is little empirical evidence on the effects of renaming schizophrenia on stigmatisation (Ellison
et al
.,
2015
). This is especially true for outcomes that affect patients and family members. Most studies either address professionals or samples of laypersons. There are very few studies that address patients and family members, those who are affected the most by stigma and discrimination. A systematic review by Yamaguchi
et al
. (
2017
) found only one study that addressed attitudes of family members of schizophrenia patients. According to the authors, this study by Nishimura
et al
. (
2005
) showed that the name change results in a less severe image of symptoms and less negative attitudes. However, there were no differences in perceptions of social adjustment problems or knowledge about the disorder (Yamaguchi
et al
.,
2017
).
Conclusion
Renaming an established and widely used term is a lengthy and complex process and its long-term outcomes are not fully known yet. There are studies that report favourable outcomes of the name changes, like, for example, improved communication between patients and clinicians and less stigmatizing attitudes towards people with schizophrenia (Yamaguchi
et al
.,
2017
). But there are also studies that found no significant differences between different names (Tranulis
et al
.,
2013
). Thus, the outcomes of renaming are still inconclusive (Yamaguchi
et al
.,
2017
). In addition, the majority of studies focus on professionals and not on those who are affected the most: patients and families. More studies including these groups need to be conducted in order to get a broader picture on the implications of a name change. Besides the limited evidence base, the aspect of cultural diversity needs to be taken into account. Even if a name change of ‘mind-split disease’ was successful in Asian countries, this does not necessarily imply that a change of schizophrenia would result in a similar outcome improvement. Changing ‘schizophrenia’ would be a whole new endeavour. And so far, the scientific community has not come to an agreement on any alternative name for schizophrenia. Finding a new name which all relevant groups agree on is an enormous challenge that still has to be faced. Probably, this will not be solved until the underlying causes of the disorder will be discovered so that schizophrenia can be re-conceptualised (Lieberman and First,
2007
). For now, the current term and concept have proven their reliability, clinical utility and validity.
Changing names does not necessarily resolve the problem of stigma as the conflicting evidence shows (Yamaguchi
et al
.,
2017
). Stigmatised properties could be carried over to a new name and a possibly positive effect would be of temporary nature (Lasalvia,
2018
). What really needs to be changed is the way that mental illness is seen by the public. It needs to be ensured that all members of society are treated respectfully and have equal rights. This is the kind of activism that is effective for all discriminated groups, regardless of their naming (Tracy,
2017
). Misconceptions and stereotypes need to be dissolved by education, positive advocacy and by setting good examples.
Conflicts of interest
None.
References
-
Allardyce J, Gaebel W, Zielasek J and van Os J (2010) Deconstructing Psychosis Conference February (2006) – The validity of schizophrenia and alternative approaches to the classification of psychosis. In Tamminga CA (ed.), Deconstructing Psychosis. Refining the Research Agenda for DSM-V. Arlington, VA: American Psychiatric Association, pp. 1–10.
[
PMC free article
]
[
PubMed
]
[
Google Scholar
]
-
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC.
[
Google Scholar
]
-
Bleuler E (1911)
Dementia praecox oder Gruppe der Schizophrenien
. Leipzig: F. Deuticke.
[
Google Scholar
]
-
Ellison N, Mason O and Scior K (2015)
Renaming schizophrenia to reduce stigma: comparison with the case of bipolar disorder
.
The British Journal of Psychiatry
206
, 341–342. [
PubMed
]
[
Google Scholar
]
-
Gaebel W (2012)
Status of psychotic disorders in ICD-11
.
Schizophrenia Bulletin
38
, 895–898.
[
PMC free article
]
[
PubMed
]
[
Google Scholar
]
-
Gaebel W, Riesbeck M, Siegert A and Zäske H (2017) Improving treatment, prevention and rehabilitation In Gaebel W, Rössler W and Sartorius N (eds),
The Stigma of Mental Illness – End of the Story?
Cham: Springer, pp. 537–550.
[
Google Scholar
]
-
Gaebel W, Riesbeck M, Zielasek J, Kerst A, Meisenzahl-Lechner E, Köllner V, Rose M, Hofmann T, Schäfer I, Lotzin A, Briken P, Klein V, Brunner F, Keeley JW, Rebello T, Andrews HF, Reed GM, Kostanjsek NF, Hasan A, Russek P and Falkai P (2018)
Internetbasierte Untersuchungen zur diagnostischen Klassifikation und Kodierung psychischer Störungen im Vergleich von ICD-11 und ICD-10
.
Fortschritte der Neurologie-Psychiatrie
86
, 163–171. [
PubMed
]
[
Google Scholar
]
-
Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C and Oepen G (1994)
One hundred years of schizophrenia. A meta-analysis of the outcome literature
.
The American Journal of Psychiatry
151
, 1409–1416. [
PubMed
]
[
Google Scholar
]
-
Henderson S and Malhi GS (2014)
Swan song for schizophrenia?
The Australian and New Zealand Journal of Psychiatry
48
, 302–305. [
PubMed
]
[
Google Scholar
]
-
Keeley JW, Reed GM, Roberts MC, Evans SC, Medina-Mora ME, Robles R, Rebello T, Sharan P, Gureje O, First MB, Andrews HF, Ayuso-Mateos JL, Gaebel W, Zielasek J and Saxena S (2016)
Developing a science of clinical utility in diagnostic classification systems field study strategies for ICD-11 mental and behavioral disorders
.
The American Psychologist
71
, 3–16. [
PubMed
]
[
Google Scholar
]
-
Keshavan MS, Nasrallah HA and Tandon R (2011)
Schizophrenia, “just the facts”: moving ahead with the schizophrenia concept
.
Schizophrenia Research
127
, 3–13.
[
PMC free article
]
[
PubMed
]
[
Google Scholar
]
-
Kraepelin E (1896)
Psychiatrie: Ein Lehrbuch fur Studierende und Aerzte
. Leipzig: Verlag von Johann Ambrosius Barth.
[
Google Scholar
]
-
Lasalvia A (2018)
Words matter. After more than a century ‘schizophrenia’ needs rebranding
.
BJPsych Advances
24
, 33–36.
[
Google Scholar
]
-
Lasalvia A, Penta E, Sartorius N and Henderson S (2015)
Should the label ‘schizophrenia’ be abandoned?
Schizophrenia Research
162
, 276–284. [
PubMed
]
[
Google Scholar
]
-
Levin T (2006)
Schizophrenia should be renamed to help educate patients and the public
.
The International Journal of Social Psychiatry
52
, 324–331. [
PubMed
]
[
Google Scholar
]
-
Lieberman J and First MB (2007)
Renaming schizophrenia. Diagnosis and treatment are more important than semantics
.
British Medical Journal
(Clinical research ed.)
334
, 108.
[
PMC free article
]
[
PubMed
]
[
Google Scholar
]
-
Maruta T and Matsumoto C (2017) Stigma and the renaming of schizophrenia In Gaebel W, Rössler W and Sartorius N (eds),
The Stigma of Mental Illness – End of the Story?
Cham: Springer, pp. 571–579.
[
Google Scholar
]
-
Mirić J, Bodatsch M, Gouzoulis-Mayfrank E and Häussermann P (2013)
Ein Fall von Morbus Bleuler? 100 Jahre ‘Dementia praecox oder Gruppe der Schizophrenien’
.
Der Nervenarzt
84
, 381–385. [
PubMed
]
[
Google Scholar
]
-
Murray RM (2006) Schizophrenia term use ‘invalid’. BBC News, 9 October. Available at
http://news.bbc.co.uk/2/hi/health/6033013.stm
(Accessed 10 May 2018).
-
Nishimura Y, Egami Y, Arisawa M and Ono Y (2005) A study on dissemination effects of name change in family members of service users In Ono Y (ed.).
Studies on the Effects of Renaming Psychiatric Disorders
. Ministry of Health, Labor and Welfare, Tokyo, pp. 51–62 (in Japanese).
[
Google Scholar
]
-
Owen MJ, Craddock N and Jablensky A (2010) The genetic deconstruction of psychosis. In Tamminga CA (ed.),
Deconstructing Psychosis. Refining the Research Agenda for DSM-V
. Arlington, VA: American Psychiatric Association, pp. 69–82.
[
Google Scholar
]
-
Reed GM, Sharan P, Rebello TJ, Keeley JW, Elena Medina-Mora M, Gureje O, Luis Ayuso-Mateos J, Kanba S, Khoury B, Kogan CS, Krasnov VN, Maj M, de Jesus Mari J, Stein DJ, Zhao M, Akiyama T, Andrews HF, Asevedo E, Cheour M, Domínguez-Martínez T, El-Khoury J, Fiorillo A, Grenier J, Gupta N, Kola L, Kulygina M, Leal-Leturia I, Luciano M, Lusu B, Nicolas J, Martínez-López I, Matsumoto C, Umukoro Onofa L, Paterniti S, Purnima S, Robles R, Sahu MK, Sibeko G, Zhong N, First MB, Gaebel W, Lovell AM, Maruta T, Roberts MC and Pike KM (2018)
The ICD-11 developmental field study of reliability of diagnoses of high-burden mental disorders. Results among adult patients in mental health settings of 13 countries
.
World Psychiatry
17
, 174–186.
[
PMC free article
]
[
PubMed
]
[
Google Scholar
]
-
Schneider K (1967)
Klinische Psychopathologie
. Stuttgart: Thieme.
[
Google Scholar
]
-
Sheehan L, Nieweglowski K and Patrick C (2017) Structures and types of stigma In Gaebel W, Rössler W and Sartorius N (eds),
The Stigma of Mental Illness – End of the Story?
Cham: Springer, pp. 43–66.
[
Google Scholar
]
-
Tamminga CA, Pearlson GD, Stan AD, Gibbons RD, Padmanabhan J, Keshavan M and Clementz BA (2017)
Strategies for advancing disease definition using biomarkers and genetics. The Bipolar and Schizophrenia Network for Intermediate Phenotypes
.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
2
, 20–27. [
PubMed
]
[
Google Scholar
]
-
Tandon R, Nasrallah HA and Keshavan MS (2009)
Schizophrenia, ‘just the facts’ 4. Clinical features and conceptualization
.
Schizophrenia Research
110
, 1–23. [
PubMed
]
[
Google Scholar
]
-
Tracy N (2017) Renaming ‘mental illness’ to ‘brain disorder’ will not erase the stigma. Available at (
https://www.huffingtonpost.com/natasha-tracy/mental-illness_b_4761908.html?guccounter=1
) (Accessed 24 May 2018).
-
Tranulis C, Lecomte T, El-Khoury B, Lavarenne A and Brodeur-Côté D (2013)
Changing the name of schizophrenia. Patient perspectives and implications for DSM-V
.
PLoS ONE
8
, e55998.
[
PMC free article
]
[
PubMed
]
[
Google Scholar
]
-
van Os J (2009
a
)
A salience dysregulation syndrome
.
The British Journal of Psychiatry
194
, 101–103. [
PubMed
]
[
Google Scholar
]
-
van Os J (2009
b
)
‘Salience syndrome’ replaces ‘schizophrenia’ in DSM-V and ICD-11. Psychiatry's evidence-based entry into the 21st century?
Acta Psychiatrica Scandinavica
120
, 363–372. [
PubMed
]
[
Google Scholar
]
-
WHO (2015) WHO best practices for naming of new human infectious diseases. Available at (
http://apps.who.int/iris/bitstream/10665/163636/1/WHO_HSE_FOS_15.1_eng.pdf?ua=1
) (Accessed 13 June 2018).
-
Yamaguchi S, Mizuno M, Ojio Y, Sawada U, Matsunaga A, Ando S and Koike S (2017)
Associations between renaming schizophrenia and stigma-related outcomes: a systematic review
.
Psychiatry and Clinical Neurosciences
71
, 347–362. [
PubMed
]
[
Google Scholar
]
Articles from
Epidemiology and Psychiatric Sciences
are provided here courtesy of
Cambridge University Press